Home » Topics » BioWorld

BioWorld
RSS

ANALYST LOWERS AMGEN EARNINGS PREDICTION

July 9, 1992

ABI FORMS SUBSIDIARY FOR ANTISENSE DRUGS

July 9, 1992

CHEMTRAK RESUMES DRUG SHIPMENTS

July 9, 1992

ANTISENSE DRUG FARING WELL IN SAFETY TRIALS

July 8, 1992

Ribi To Expand Manufacturing Facility

July 8, 1992

PPL RAISES $11.6 MILLION IN FINANCING

July 8, 1992

WAITING PERIOD EXPIRES FOR SCIOS-NOVA MERGER

July 8, 1992

IMMUNOMEDICS FOUNDER STEPS ASIDE

July 8, 1992

ELAN STOCK PURCHASE AUTHORIZED

July 8, 1992

OPPENHEIMER FUNDS INVEST IN PGS

July 8, 1992

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...